Search results for: Maria Lowe

Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?

29 April 2021

…value of £20,000-£30,000 per quality-adjusted life year (QALY) gained (£20-30k/QALY), it will likely be made available within the NHS. Lowering this threshold would mean that fewer health technologies would be…

Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives

26 November 2024

…of their life, even if the highest levels of hospice-level care are available to patients, using conservative assumptions that provide the lowest possible estimate. This is a 15% increase between…

OHE submission to the UK Parliamentary Inquiry on an Ageing Society

20 May 2025

…age-based differences in the number of days reported as absenteeism and presenteeism for the respondents in our sample (in absolute terms, numbers were actually lower across the board for individuals aged…

US Pharmaceutical Pricing Policies

…access to necessary medications, particularly affecting those from lower socioeconomic backgrounds. The considerable profits enjoyed by the pharmaceutical industry juxtaposed with restricted access to essential treatments raise concerns about equity…

Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order

2 June 2025

…of global pharmaceutical prices with American patients paying lower prices. Pegging US drug prices to other countries’ is not a new idea This EO marks a significant departure from a previous…

Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs

12 March 2019

…the discussion at that meeting. Rebates are a key negotiating tool for payers and help produce a lower ‘net’ price for drugs that can help reduce the overall costs of…

Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates

1 March 2019

…to be answered. Rebates are a key negotiating tool for payers and help produce a lower “net” price for drugs that can help reduce the overall costs of drug spending….

OHE Annual Lecture: Universal Health Coverage: the Holy Grail?

8 June 2014, 11:00pm

…The health systems of most other high income countries similarly embody the ideal of universal health coverage. Yet low- and lower-middle-income countries have recently been on the receiving end of…

Part 2: 2010 Lecture on US Health Reform

27 July 2010

…most likely to purchase individual policies. Finally, the new financial penalties for many individuals who do not purchase insurance will be lower – often dramatically so – than the cost…